Depression is a disease of growing incidence and economic burden worldwide. In view of increasing treatment resistance, new therapeutic approaches are urgently needed. In addition to its gonadal functions, testosterone has many effects on the central nervous system. An association between testosterone levels and depressive symptoms has been proposed. Many hormones and neurotransmitters are involved in the aetiology and the course of depression including serotonin, dopamine, noradrenaline, vasopressin and cortisol. Testosterone is known to interact with them. Preclinical data suggest that testosterone has antidepressant potential. However, the data from clinical studies have been inconsistent. This review provides a critical overview on the currently available preclinical and clinical literature and concludes with clinical recommendations.
Aikey JL Nyby JG Anmuth DM James PJ (2002) Testosterone rapidly reduces anxiety in male house mice (Mus musculus). Horm Behav42: 448–460.
2.
Alexander GM Swerdloff RS Wang C Davidson T McDonald V Steiner B (1998) Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm Behav33: 85–94.
3.
Almeida OP Waterreus A Spry N Flicker L Martins RN (2004) One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology29: 1071–1081.
4.
Altman J Das GD (1965) Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol124: 319–335.
5.
Amsterdam JD Winokur A Caroff S Snyder P (1981) Gonadotropin release after administration of GnRH in depressed patients and healthy volunteers. J Affect Disord3: 367–380.
6.
Angst J Gamma A Gastpar M Lepine JP Mendlewicz J Tylee A (2002) Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci252: 201–209.
7.
Archer J (1991) The influence of testosterone on human aggression. Br J Psychol82: 1–28.
8.
Arlt W (2006) Androgen therapy in women. Eur J Endocrinol154: 1–11.
9.
Azad N Pitale S Barnes WE Friedman N (2003) Testosterone treatment enhances regional brain perfusion in hypogonadal men. J Clin Endocrinol Metab88: 3064–3068.
10.
Bachmann G Bancroft J Braunstein G Burger H Davis S Dennerstein L (2002) Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril77: 660–665.
11.
Baischer W Koinig G Hartmann B Huber J Langer G (1995) Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology20: 553–559.
12.
Bakhshi V Elliott M Gentili A Godschalk M Mulligan T (2000) Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc48: 550–553.
13.
Balthazart J Ball GF (2006) Is brain estradiol a hormone or a neurotransmitter. Trends Neurosci29: 241–249.
14.
Barnhart KT Freeman E Grisso JA Rader DJ Sammel M Kapoor S (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab84: 3896–3902.
15.
Barrett-Connor E Goodman-Gruen D Patay B (1999a) Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab84: 3681–3685.
16.
Barrett-Connor E von Muhlen DG Kritz-Silverstein D (1999b) Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab84: 573–577.
17.
Bebbington P Dunn G Jenkins R Lewis G Brugha T Farrell M (2003) The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Int Rev Psychiatry15: 74–83.
18.
Bell S Shipman M Bystritsky A Haifley T (2006) Fluoxetine treatment and testosterone levels. Ann Clin Psychiatry18: 19–22.
19.
Bhasin S Storer TW Asbel-Sethi N Kilbourne A Hays R Sinha-Hikim I (1998) Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab83: 3155–3162.
20.
Bhasin S Storer TW Javanbakht M Berman N Yarasheski KE Phillips J (2000) Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA283: 763–770.
21.
Booth A Johnson DR Granger DA (1999) Testosterone and men's depression: the role of social behavior. J Health Soc Behav40: 130–140.
22.
Breedlove SM Arnold AP (1983) Hormonal control of a developing neuromuscular system. II. Sensitive periods for the androgen-induced masculinization of the rat spinal nucleus of the bulbocavernosus. J Neurosci3: 424–432.
23.
Broadbear JH Pierce BN Clarke IJ Canny BJ (2005) Role of sex and sex steroids in mediating pituitary-adrenal responses to acute buspirone treatment in sheep. J Neuroendocrinol17: 804–810.
24.
Brower KJ Blow FC Young JP Hill EM (1991) Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict86: 759–768.
25.
Brugue E Vieta E (2007) Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications. Prog Neuropsychopharmacol Biol Psychiatry31: 275–282.
26.
Bschor T Lewitzka U Sasse J Adli M Koberle U Bauer M (2003) Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. Pharmacopsychiatry36 (Suppl. 3): S230–S234.
27.
Burris AS Banks SM Carter CS Davidson JM Sherins RJ (1992) A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl13: 297–304.
28.
Canoine V Fusani L Schlinger B Hau M (2007) Low sex steroids, high steroid receptors: Increasing the sensitivity of the nonreproductive brain. Dev Neurobiol67: 57–67.
29.
Carpenter LL Friehs GM Tyrka AR Rasmussen S Price LH Greenberg BD (2006) Vagus nerve stimulation and deep brain stimulation for treatment resistant depression. Med Health R I89: 140–141.
30.
Caspi A Sugden K Moffitt TE Taylor A Craig IW Harrington H (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science301: 386–389.
31.
Cavallini G Caracciolo S Vitali G Modenini F Biagiotti G (2004) Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology63: 641–646.
32.
Charlier TD Ball GF Balthazart J (2006) Plasticity in the expression of the steroid receptor coactivator 1 in the Japanese quail brain: effect of sex, testosterone, stress and time of the day. Neuroscience140: 1381–1394.
33.
Chisu V Manca P Lepore G Gadau S Zedda M Farina V (2006) Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell line. Arch Ital Biol144: 63–73.
34.
Christiansen K (2001) Behavioural effects of androgen in men and women. J Endocrinol170: 39–48.
35.
Colangelo LA Sharp L Kopp P Scholtens D Chiu BC Liu K Gapstur SM (2007) Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: The CARDIA Male Hormone Study.Psychoneuroendocrinology 32: 951–958.
36.
Commins D Yahr P (1984) Adult testosterone levels influence the morphology of a sexually dimorphic area in the Mongolian gerbil brain. J Comp Neurol224: 132–140.
37.
Coppen A Wood K (1982) 5-Hydroxytryptamine in the pathogenesis of affective disorders. Adv Biochem Psychopharmacol34: 249–258.
38.
Daniell HW Lentz R Mazer NA (2006) Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain7: 200–210.
39.
Davies RH Harris B Thomas DR Cook N Read G Riad-Fahmy D (1992) Salivary testosterone levels and major depressive illness in men. Br J Psychiatry161: 629–632.
40.
Davis SR Goldstat R Papalia MA Shah S Kulkarni J Donath S (2006) Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause13: 37–45.
41.
Dawood T Williams MR Fullerton MJ Myles K Schuijers J Funder JW (2005) Glucocorticoid responses to stress in castrate and testosterone-replaced rams. Regul Pept125: 47–53.
42.
Delhez M Hansenne M Legros JJ (2003) Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinology28: 863–874.
43.
Dias BG Crews D (2006) Serotonergic modulation of male-like pseudocopulatory behavior in the parthenogenetic whiptail lizard, Cnemidophorus uniparens. Horm Behav50: 401–409.
44.
Dias RS Kerr-Correa F Moreno RA Trinca LA Pontes A Halbe HW (2006) Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study. Menopause13: 202–211.
Doering CH Brodie HK Kraemer HC Moos RH Becker HB Hamburg DA (1975) Negative affect and plasma testosterone: a longitudinal human study. Psychosom Med37: 484–491.
47.
Dubois-Dauphin M Barberis C de Bilbao F (1996) Vasopressin receptors in the mouse (Mus musculus) brain: sex-related expression in the medial preoptic area and hypothalamus. Brain Res743: 32–39.
48.
Ebinger M Behl C Rosenhagen M Uhr M (2007) P-glycoprotein has negligible effects on estradiol and testosterone in mice. Neurosci Lett427: 6–9.
49.
Edinger KL Frye CA (2005) Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology30: 418–430.
50.
Edinger KL Frye CA (2006) Intrahippocampal administration of an androgen receptor antagonist, flutamide, can increase anxiety-like behavior in intact and DHT-replaced male rats. Horm Behav50: 216–222.
51.
Engesser-Cesar C Anderson AJ Cotman CW (2007) Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord. Neuroscience144: 1033–1044.
52.
Estrada M Varshney A Ehrlich BE (2006) Elevated testosterone induces apoptosis in neuronal cells. J Biol Chem281: 25492–25501.
53.
Fink G Sumner B Rosie R Wilson H McQueen J (1999) Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res105: 53–68.
54.
Fink G Sumner BE Mcqueen JK Wilson H Rosie R (1998) Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol25: 764–775.
55.
Floter A Nathorst-Boos J Carlstrom K von Schoultz B (2002) Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric5: 357–365.
56.
Forlano PM Schlinger BA Bass AH (2006) Brain aromatase: new lessons from non-mammalian model systems. Front Neuroendocrinol27: 247–274.
57.
Galea LA Spritzer MD Barker JM Pawluski JL (2006) Gonadal hormone modulation of hippocampal neurogenesis in the adult. Hippocampus16: 225–232.
58.
Gershenfeld HK Philibert RA Boehm GW (2005) Looking forward in geriatric anxiety and depression: implications of basic science for the future. Am J Geriatr Psychiatry13: 1027–1040.
59.
Goldstat R Briganti E Tran J Wolfe R Davis SR (2003) Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause10: 390–398.
60.
Graham CA Bancroft J Doll HA Greco T Tanner A (2007) Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women. Psychoneuroendocrinology32: 246–255.
61.
Gray PB Singh AB Woodhouse LJ Storer TW Casaburi R Dzekov J (2005) Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab90: 3838–3846.
62.
Greenberg RM Kellner CH (2005) Electroconvulsive therapy: a selected review. Am J Geriatr Psychiatry13: 268–281.
63.
Grimes JM Ricci LA Melloni RH (2006) Plasticity in anterior hypothalamic vasopressin correlates with aggression during anabolic-androgenic steroid withdrawal in hamsters. Behav Neurosci120: 115–124.
64.
Grinspoon S Corcoran C Stanley T Baaj A Basgoz N Klibanski A (2000) Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab85: 60–65.
65.
Haren MT Malmstrom TK Banks WA Patrick P Miller DK Morley JE (2007) Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas57: 347–360.
66.
Haren MT Wittert GA Chapman IM Coates P Morley JE (2005) Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas50: 124–133.
67.
Hernandez-Rauda R Aldegunde M (2002) Effects of acute 17alpha-methyltestosterone, acute 17beta-estradiol, and chronic 17alpha-methyltestosterone on dopamine, norepinephrine and serotonin levels in the pituitary, hypothalamus and telencephalon of rainbow trout (Oncorhynchus mykiss). J Comp Physiol [B]172: 659–667.
68.
Heuett WJ Qian H (2006) A stochastic model of oscillatory blood testosterone levels. Bull Math Biol68: 1383–1399.
69.
Heuser I (2002) Depression, endocrinologically a syndrome of premature aging. Maturitas41 (Suppl. 1): S19–S23.
70.
Holsboer F (2003) High-quality antidepressant discovery by understanding stress hormone physiology. Ann N Y Acad Sci1007: 394–404.
71.
Houser BB (1979) An investigation of the correlation between hormonal levels in males and mood, behavior and physical discomfort. Horm Behav12: 185–197.
72.
Iosifescu DV Nierenberg AA Mischoulon D Perlis RH Papakostas GI Ryan JL (2005) An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. J Clin Psychiatry66: 1038–1042.
73.
Jacobs C Van Den Broeck W Simoens P (2006) Increased number of neurons expressing androgen receptor in the basolateral amygdala of pathologically aggressive dogs. J Vet Med A Physiol Pathol Clin Med53: 334–339.
74.
Janowsky JS Chavez B Orwoll E (2000) Sex steroids modify working memory. J Cogn Neurosci12: 407–414.
75.
Janowsky JS Oviatt SK Orwoll ES (1994) Testosterone influences spatial cognition in older men. Behav Neurosci108: 325–332.
76.
Kaufman JM Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev26: 833–876.
77.
Keck ME (2006) Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids31: 241–250.
78.
Keck ME Wigger A Welt T Muller MB Gesing A Reul JM (2002) Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology26: 94–105.
79.
Kenny AM Fabregas G Song C Biskup B Bellantonio S (2004) Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci59: 75–78.
80.
Kessler RC (2003) Epidemiology of women and depression. J Affect Disord74: 5–13.
81.
Kessler RC McGonagle KA Zhao S Nelson CB Hughes M Eshleman S (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry51: 8–19.
82.
Kornstein SG Schatzberg AF Thase ME Yonkers KA McCullough JP Keitner GI (2000) Gender differences in chronic major and double depression. J Affect Disord60: 1–11.
83.
Kunelius P Lukkarinen O Hannuksela ML Itkonen O Tapanainen JS (2002) The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study. J Clin Endocrinol Metab87: 1467–1472.
84.
Kurz EM Sengelaub DR Arnold AP (1986) Androgens regulate the dendritic length of mammalian motoneurons in adulthood. Science232: 395–398.
85.
Levitt AJ Joffe RT (1988) Total and free testosterone in depressed men. Acta Psychiatr Scand77: 346–348.
86.
Liu PY Yee B Wishart SM Jimenez M Jung DG Grunstein RR (2003) The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab88: 3605–3613.
87.
Lucassen PJ Heine VM Muller MB van der Beek EM Wiegant VM De Kloet ER (2006) Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets5: 531–546.
88.
Luisi M Franchi F (1980) Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients. J Endocrinol Invest3: 305–308.
89.
LY L. P., Jimenez, M, Zhuang, TN, Celermajer, DS, Conway, AJ, Handelsman, DJ (2001) A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab86: 4078–4088.
90.
MacLusky NJ Hajszan T Prange-Kiel J Leranth C (2006) Androgen modulation of hippocampal synaptic plasticity. Neuroscience138: 957–965.
91.
Maggi A Perez J (1985) Role of female gonadal hormones in the CNS: clinical and experimental aspects. Life Sci37: 893–906.
92.
Makhlouf AA; Mohamed MA; Seftel AD; Neiderberger C; (2008) Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction. Int J Impot Res 20: 157–161.
93.
Martinez-Mota L Fernandez-Guasti A (2004) Testosterone-dependent antidepressant-like effect of noradrenergic but not of serotonergic drugs. Pharmacol Biochem Behav78: 711–718.
94.
Matsumoto AM (1990) Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. J Clin Endocrinol Metab70: 282–287.
95.
Mazur A (1995) Biosocial models of deviant behavior among male army veterans. Biol Psychol41: 271–293.
96.
McEwen BS Alves SE (1999) Estrogen actions in the central nervous system. Endocr Rev20: 279–307.
97.
McMahon FJ Buervenich S Charney D Lipsky R Rush AJ Wilson AF (2006) Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet78: 804–814.
98.
McNicholas TA Dean JD Mulder H Carnegie C Jones NA (2003) A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int91: 69–74.
99.
Miller KK Wexler TL Zha AM Lawson EA Meenaghan EM Misra M (2007) Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry68: 959–965.
100.
Morley JE (2003) Testosterone and behavior. Clin Geriatr Med19: 605–616.
101.
Morsink LF Vogelzangs N Nicklas BJ Beekman AT Satterfield S Rubin SM (2007) Associations between sex steroid hormone levels and depressive symptoms in elderly men and women: Results from the Health ABC study.Psychoneuroendocrinology.
102.
Muller M Grobbee DE Thijssen JH Van Den Beld AW Van Der Schouw YT (2003) Sex hormones and male health: effects on components of the frailty syndrome. Trends Endocrinol Metab14: 289–296.
103.
Muller MB Holsboer F (2006) Mice with mutations in the HPA-system as models for symptoms of depression. Biol Psychiatry59: 1104–1115.
104.
Myers LS Dixen J Morrissette D Carmichael M Davidson JM (1990) Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab70: 1124–1131.
105.
Nemeroff CB (2005) Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psychiatry66 (Suppl. 8): 13–21.
106.
Newberg A Amsterdam J Shults J (2007) Dopamine transporter density may be associated with the depressed affect in healthy subjects. Nucl Med Commun28: 3–6.
107.
O'connor DB, Archer, J, Wu, FC (2004) Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab89: 2837–2845.
108.
Orengo CA Fullerton G Tan R (2004) Male depression: a review of gender concerns and testosterone therapy. Geriatrics59: 24–30.
109.
Orengo CA Fullerton L Kunik ME (2005) Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy. J Geriatr Psychiatry Neurol18: 20–24.
110.
Ozcan ME Banoglu R (2003) Gonadal hormones in schizophrenia and mood disorders. Eur Arch Psychiatry Clin Neurosci253: 193–196.
111.
Parducz A Hajszan T Maclusky NJ Hoyk Z Csakvari E Kurunczi A (2006) Synaptic remodeling induced by gonadal hormones: neuronal plasticity as a mediator of neuroendocrine and behavioral responses to steroids. Neuroscience138: 977–985.
112.
Park SK Strouse DA Selmanoff M (1996) Prolactin- and testosterone-induced inhibition of LH secretion after orchidectomy: role of catecholaminergic neurones terminating in the diagonal band of Broca, medial preoptic nucleus and median eminence. J Endocrinol148: 291–301.
113.
Perry PJ Yates WR Williams RD Andersen AE MacIndoe JH Lund BC (2002) Testosterone therapy in late-life major depression in males. J Clin Psychiatry63: 1096–1101.
114.
Piccinelli M Wilkinson G (2000) Gender differences in depression. Critical review. Br J Psychiatry177: 486–492.
115.
Pope HG Cohane GH Kanayama G Siegel AJ Hudson JI (2003) Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry160: 105–111.
116.
Pope HG Katz DL (1988) Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry145: 487–490.
117.
Pope HG Katz DL (1990) Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry51: 28–31.
118.
Pope HG Kouri EM Hudson JI (2000) Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry57: 133–140discussion 155–156.
119.
Poretsky L Brillon DJ Ferrando S Chiu J McElhiney M Ferenczi A (2006) Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial. Metabolism55: 858–870.
120.
Pozzo Miller LD Aoki A (1991) Stereological analysis of the hypothalamic ventromedial nucleus. II. Hormone-induced changes in the synaptogenic pattern. Brain Res Dev Brain Res61: 189–196.
121.
Putnam SK Sato S Riolo JV Hull EM (2005) Effects of testosterone metabolites on copulation, medial preoptic dopamine, and NOS-immunoreactivity in castrated male rats. Horm Behav47: 513–522.
122.
Rabkin JG McElhiney MC Rabkin R McGrath PJ Ferrando SJ (2006) Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry163: 59–66.
123.
Rabkin JG Wagner GJ McElhiney MC Rabkin R Lin SH (2004) Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial. J Clin Psychopharmacol24: 379–385.
124.
Rabkin JG Wagner GJ Rabkin R (2000) A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry57: 141–147discussion 155–156.
125.
Roselli CE Resko JA (2001) Cytochrome P450 aromatase (CYP19) in the non-human primate brain: distribution, regulation, and functional significance. J Steroid Biochem Mol Biol79: 247–253.
126.
Rubin RT Poland RE Lesser IM (1989) Neuroendocrine aspects of primary endogenous depression VIII. Pituitary-gonadal axis activity in male patients and matched control subjects. Psychoneuroendocrinology14: 217–229.
127.
Rubinow DR Schmidt PJ (1996) Androgens, brain, and behavior. Am J Psychiatry153: 974–984.
128.
Rupprecht R (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology28: 139–168.
129.
Rupprecht R Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci22: 410–416.
130.
Rupprecht R Rupprecht C Rupprecht M Noder M Schwarz W (1988) Different reactivity of the hypothalamo-pituitary-gonadal-axis in depression and normal controls. Pharmacopsychiatry21: 438–439.
131.
Sato T Matsumoto T Kawano H Watanabe T Uematsu Y Sekine K (2004) Brain masculinization requires androgen receptor function. Proc Natl Acad Sci U S A101: 1673–1678.
132.
Schlinger BA (1997) The activity and expression of aromatase in songbirds. Brain Res Bull44: 359–364.
133.
Schmidt PJ Berlin KL Danaceau MA Neeren A Haq NA Roca CA (2004) The effects of pharmacologically induced hypogonadism on mood in healthy men. Arch Gen Psychiatry61: 997–1004.
134.
Schmidt PJ Rubinow DR (1997) Neuroregulatory role of gonadal steroids in humans. Psychopharmacol Bull33: 219–220.
135.
Schneider HJ Aimaretti G Kreitschmann-Andermahr I Stalla GK Ghigo E (2007) Hypopituitarism. Lancet369: 1461–1470.
Schroeder JP Packard MG (2000) Role of dopamine receptor subtypes in the acquisition of a testosterone conditioned place preference in rats. Neurosci Lett282: 17–20.
138.
Schulz KM Menard TA Smith DA Albers HE Sisk CL (2006) Testicular hormone exposure during adolescence organizes flank-marking behavior and vasopressin receptor binding in the lateral septum. Horm Behav50: 477–483.
139.
Schweiger U Deuschle M Weber B Korner A Lammers CH Schmider J (1999) Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med61: 292–296.
140.
Seale JV Wood SA Atkinson HC Lightman SL Harbuz MS (2005) Organizational role for testosterone and estrogen on adult hypothalamic-pituitary-adrenal axis activity in the male rat. Endocrinology146: 1973–1982.
141.
Seidman SN (2003) Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions. World J Biol Psychiatry4: 14–20.
142.
Seidman SN (2006) Normative hypogonadism and depression: Does 'andropause' exist. Int J Impot Res18: 415–422.
143.
Seidman SN Araujo AB Roose SP Devanand DP Xie S Cooper TB (2002) Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry159: 456–459.
144.
Seidman SN Araujo AB Roose SP McKinlay JB (2001a) Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry50: 371–376.
145.
Seidman SN Miyazaki M Roose SP (2005) Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial. J Clin Psychopharmacol25: 584–588.
146.
Seidman SN Rabkin JG (1998) Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord48: 157–161.
147.
Seidman SN Roose SP (2006) The sexual effects of testosterone replacement in depressed men: randomized, placebo-controlled clinical trial. J Sex Marital Ther32: 267–273.
148.
Seidman SN Spatz E Rizzo C Roose SP (2001b) Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry62: 406–412.
149.
Seidman SN Walsh BT (1999) Testosterone and depression in aging men. Am J Geriatr Psychiatry7: 18–33.
150.
Shemisa K Kunnathur V Liu B Salvaterra TJ Dluzen DE (2006) Testosterone modulation of striatal dopamine output in orchidectomized mice. Synapse60: 347–353.
151.
Sherwin BB (1988) Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord14: 177–187.
152.
Shifren JL (2002) Androgen deficiency in the oophorectomized woman. Fertil Steril77 (Suppl. 4): S60–S62.
153.
Shores MM Moceri VM Sloan KL Matsumoto AM Kivlahan DR (2005) Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Psychiatry66: 7–14.
154.
Shores MM Sloan KL Matsumoto AM Moceri VM Felker B Kivlahan DR (2004) Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry61: 162–167.
155.
Sih R Morley JE Kaiser FE Perry HM Patrick P Ross C (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab82: 1661–1667.
156.
Steidle C Schwartz S Jacoby K Sebree T Smith T Bachand R (2003) AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab88: 2673–2681.
157.
Steiner M Dunn E Born L (2003) Hormones and mood: from menarche to menopause and beyond. J Affect Disord74: 67–83.
158.
Stoffel-Wagner B (2001) Neurosteroid metabolism in the human brain. Eur J Endocrinol145: 669–679.
159.
Su TP Pagliaro M Schmidt PJ Pickar D Wolkowitz O Rubinow DR (1993) Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA269: 2760–2764.
160.
Sun MK Alkon DL (2006) Differential gender-related vulnerability to depression induction and converging antidepressant responses in rats. J Pharmacol Exp Ther316: 926–932.
161.
Swaab DF Bao AM Lucassen PJ (2005) The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev4: 141–194.
162.
Szczypka MS Zhou QY Palmiter RD (1998) Dopamine-stimulated sexual behavior is testosterone dependent in mice. Behav Neurosci112: 1229–1235.
163.
T'sjoen G. G., De Vos, S, Goemaere, S, Van Pottelbergh, I, Dierick, M, Van Heeringen, C, Kaufman, JM (2005) Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc53: 636–642.
164.
Tan RS Salazar JA (2004) Risks of testosterone replacement therapy in ageing men. Expert Opin Drug Saf3: 599–606.
165.
Tricker R Casaburi R Storer TW Clevenger B Berman N Shirazi A (1996) The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men–a clinical research center study. J Clin Endocrinol Metab81: 3754–3758.
166.
Unden F Ljunggren JG Beck-Friis J Kjellman BF Wetterberg L (1988) Hypothalamic-pituitary-gonadal axis in major depressive disorders. Acta Psychiatr Scand78: 138–146.
167.
Vermeulen A Kaufman JM (1995) Ageing of the hypothalamo-pituitary-testicular axis in men. Horm Res43: 25–28.
168.
Vogel W Klaiber EL Broverman DM (1985) A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry46: 6–8.
169.
Wang C Alexander G Berman N Salehian B Davidson T McDonald V (1996) Testosterone replacement therapy improves mood in hypogonadal men–a clinical research center study. J Clin Endocrinol Metab81: 3578–3583.
170.
Wang C Cunningham G Dobs A Iranmanesh A Matsumoto AM Snyder PJ (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab89: 2085–2098.
171.
Wang C Swerdloff RS Iranmanesh A Dobs A Snyder PJ Cunningham G (2000) Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab85: 2839–2853.
172.
Weissman MM Olfson M (1995) Depression in women: implications for health care research. Science269: 799–801.
173.
Weltzien FA Pasqualini C Sebert ME Vidal B Le Belle N Kah O (2006) Androgen-dependent stimulation of brain dopaminergic systems in the female European eel (Anguilla anguilla). Endocrinology147: 2964–2973.
174.
Wierman ME Basson R Davis SR Khosla S Miller KK Rosner W (2006) Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab91: 3697–3710.
175.
Wilson IC Prange AJ Lara PP (1974) Methyltestosterone with imipramine in men: conversion of depression to paranoid reaction. Am J Psychiatry131: 21–24.
Yates WR Perry PJ MacIndoe J Holman T Ellingrod V (1999) Psychosexual effects of three doses of testosterone cycling in normal men. Biol Psychiatry45: 254–260.
178.
Zarate CA Singh JB Carlson PJ Brutsche NE Ameli R Luckenbaugh DA (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry63: 856–864.
179.
Zweifel JE O'brien, WH (1997) A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology22: 189–212.
